E2open (ETWO) Reports In-Line Q1 EPS
Get Alerts ETWO Hot Sheet
Join SI Premium – FREE
E2open (NYSE: ETWO) reported Q1 EPS of $0.05, in-line with the analyst estimate of $0.05. Revenue for the quarter came in at $160.1 million versus the consensus estimate of $173.04 million.
Financial Outlook for Fiscal Year 2024:
As of July 10, 2023, e2open is reiterating full year 2024 guidance previously provided on May 1, 2023, and providing second quarter 2024 guidance as follows:
Fiscal 2024 Subscription GAAP Revenue
GAAP subscription revenue for fiscal 2024 is expected to be in the range of $545 million to $555 million, reflecting a 3.2% organic growth rate at the mid-point.
Fiscal 2024 Total GAAP Revenue
Total GAAP revenue for fiscal 2024 is expected to be in the range of $655 million to $670 million, reflecting a 1.6% organic growth rate at the mid-point.
Fiscal Second Quarter 2024 GAAP Subscription Revenue
GAAP subscription revenue for the fiscal second quarter of 2024 is expected to be in the range of $132 million to $135 million, reflecting a 1.4% organic growth rate at the mid-point.
Fiscal 2024 Non-GAAP Gross Profit Margin
Non-GAAP gross profit margin for fiscal 2024 is expected to be in the range of 68% to 70%.
Fiscal 2024 Adjusted EBITDA
Adjusted EBITDA for fiscal 2024 is expected to be in the range of $218 million to $228 million, reflecting an implied adjusted EBITDA margin in the range of 33% to 34%.
NOTE: E2open is unable to quantify certain amounts that would be required to be included in the most directly comparable GAAP financial measures for non-GAAP gross profit margin or adjusted EBITDA without unreasonable effort, and therefore no reconciliation of certain forward-looking non-GAAP financial measures for non-GAAP gross profit margin or adjusted EBITDA is included.
For earnings history and earnings-related data on E2open (ETWO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share